3 results match your criteria: "Foundation IRCCS National Tumour Institute[Affiliation]"
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Eur J Nucl Med Mol Imaging
April 2022
Department of Nuclear medicine, University clinic Essen, Essen, Germany.
Primary liver tumours (i.e. hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide.
View Article and Find Full Text PDFHo microsphere scout dose for more accurate radioembolization treatment planning.
Eur J Nucl Med Mol Imaging
April 2020
Nuclear Medicine, Foundation IRCCS National Tumour Institute, Milan, Italy.
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.
Ann Oncol
June 2009
Medical Oncology Unit 2, Foundation IRCCS National Tumour Institute, Milan, Italy.
Background: This clinical trial assessed the efficacy of pemetrexed combined with oxaliplatin (PEMOX) in patients with advanced gastric cancer (AGC).
Patients And Methods: Forty-four patients with untreated AGC were enrolled to evaluate response rate (RR). Patients received pemetrexed (500 mg/m(2)) with vitamin supplementation and oxaliplatin (120 mg/m(2)) every 21 days for six cycles or until disease progression occurred.